Sustained clinical efficacy after repeat intradetrusor botulinum toxin type A in the treatment of neurogenic detrusor overactivity.
Keng Siang
KS
Png
Khai-Lee
KL
Toh
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D017063:Outcome Assessment, Health Care; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A